Biological applications of Ru(II) polypyridyl complexes

被引:71
作者
Mital, Mariusz [1 ,2 ]
Ziora, Zyta [3 ]
机构
[1] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic, Australia
[2] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland
[3] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia
关键词
Antimicrobial properties; Cancer; DNA interaction; Enzyme inhibition; Photoactivation; Ru(II) polypyridyl complexes; RESISTANT STAPHYLOCOCCUS-AUREUS; MOLECULAR LIGHT SWITCH; PHOTODYNAMIC INACTIVATION; RUTHENIUM(II) COMPLEXES; DNA-BINDING; PYRIDINE ANALOGS; VISIBLE-LIGHT; NAMI-A; ANTICANCER ACTIVITY; TOPOISOMERASE-II;
D O I
10.1016/j.ccr.2018.02.013
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Ru(II) polypyridyl complexes are of great interest for their unique biological, photophysical, optical, catalytic and electronic properties. This class of complexes demonstrates a number of potential therapeutic applications via interactions with DNA, enzymes and cell membranes, leading to cell death. Metal-based drugs have many common mechanisms of action when acting against cancer and bacterial cells. Even though it was discovered over 50 years ago, the best-known anticancer agent is still cisplatin and the high toxicity and potentially serious complications point to the need for improved drug treatments. Similarly, the first antibiotics introduced in the 1930s against bacterial infection started "the golden age of antibiotics", but the increased number of antibiotic-resistant bacteria has become a global health problem. Recent research has shown that Ru(II) polypyridyl complexes have the potential to be used for the treatment of both cancer and bacterial infections, and in this review the most promising complexes are presented with their anticancer and antimicrobial properties discussed in detail. Crown Copyright (C) 2018 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:434 / 458
页数:25
相关论文
共 145 条
[1]   Aryl-Substituted Ruthenium(II) Complexes: A Strategy for Enhanced Photocleavage and Efficient DNA Binding [J].
Abreu, Felipe Diogenes ;
Paulo, Tercio de F. ;
Gehlen, Marcelo H. ;
Ando, Romulo A. ;
Lopes, Luiz G. F. ;
Gondim, Ana Claudia S. ;
Vasconcelos, Mayron A. ;
Teixeira, Edson H. ;
Silva Sousa, Eduardo Henrique ;
Moreira de Carvalho, Idalina Maria .
INORGANIC CHEMISTRY, 2017, 56 (15) :9084-9096
[2]   Allosteric cross-talk in chromatin can mediate drug-drug synergy [J].
Adhireksan, Zenita ;
Palermo, Giulia ;
Riedel, Tina ;
Ma, Zhujun ;
Muhammad, Reyhan ;
Rothlisberger, Ursula ;
Dyson, Paul J. ;
Davey, Curt A. .
NATURE COMMUNICATIONS, 2017, 8
[3]   Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis [J].
Ahmad, Zahoor ;
Sharma, Sadhna ;
Khuller, G. K. ;
Singh, Pushpendra ;
Faujdar, Jaya ;
Katoch, V. M. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (06) :543-544
[4]   Synthesis, DNA Cleavage Activity, Cytotoxicity, Acetylcholinesterase Inhibition, and Acute Murine Toxicity of Redox-Active Ruthenium(II) Polypyridyl Complexes [J].
Alatrash, Nagham ;
Narh, Eugenia S. ;
Yadav, Abhishek ;
Kim, Mahn-Jong ;
Janaratne, Thamara ;
Gabriel, James ;
MacDonnell, Frederick M. .
CHEMMEDCHEM, 2017, 12 (13) :1055-1069
[5]   SYNTHESIS, MOLECULAR-STRUCTURE, AND CHEMICAL BEHAVIOR OF HYDROGEN TRANS-BIS(DIMETHYL SULFOXIDE)TETRACHLORORUTHENATE(III) AND MER-TRICHLOROTRIS(DIMETHYL SULFOXIDE)RUTHENIUM(III) - THE 1ST FULLY CHARACTERIZED CHLORIDE DIMETHYL-SULFOXIDE RUTHENIUM(III) COMPLEXES [J].
ALESSIO, E ;
BALDUCCI, G ;
CALLIGARIS, M ;
COSTA, G ;
ATTIA, WM ;
MESTRONI, G .
INORGANIC CHEMISTRY, 1991, 30 (04) :609-618
[6]   Ruthenium antimetastatic agents [J].
Alessio, E ;
Mestroni, G ;
Bergamo, A ;
Sava, G .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (15) :1525-1535
[7]   Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective [J].
Alessio, Enzo .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2017, (12) :1549-1560
[8]  
Allardyce CS, 2001, PLATIN MET REV, V45, P62
[9]  
Almeida A, 2015, FUTURE MED CHEM, V7, P1221, DOI [10.4155/FMC.15.59, 10.4155/fmc.15.59]
[10]   Photodynamic inactivation of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus with Ru(II)-based type I/type II photosensitizers [J].
Arenas, Yaxal ;
Monro, Susan ;
Shi, Ge ;
Mandel, Arkady ;
McFarland, Sherri ;
Lilge, Lothar .
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2013, 10 (04) :615-625